View this email in your browser

New and exciting things planned for the November 2020 #EuroTestWeek

Join us for our series of FREE live webinars during the 2020 November European Testing Week. The series will focus on “Challenges and opportunities for testing during the COVID-19 pandemic throughout the WHO European Region.” The webinar series will highlight the different experiences of organisations throughout Europe who have adapted testing services to mitigate the impact of COVID-19.

Webinar topics and dates include:
  1. Testing vulnerable populations in COVID-restricted contexts (organised by HIV Prevention England in partnership with European Testing Week)
    • Monday, 23 November 2020, 15:00-16:15 CET
  2. Integrating testing for HIV and/or viral hepatitis and COVID-19
    • Wednesday, 25 November 2020, 16:00-16:45 CET
  3. HIV self-testing – opportunities and challenges during the COVID-19 pandemic
    • Friday, 27 November 2020, 13:00-13:45 CET
More information about registration will be shared soon! In the meantime, you can always check back on the webinar page on the ETW website for updates.

Take part in a regional survey to assess the impact of COVID-19 on testing for HIV, viral hepatitis & STIs throughout the WHO European region

A EuroTEST-led consortium has developed an online survey to understand how this global crisis has affected testing services and how to mitigate its effects on the responses to the epidemics going forward.
The main objective of the survey is to assess the impact of COVID-19 on testing for HIV, HBV, HCV, chlamydia, syphilis and gonorrhoea among the different actors of the testing response including: 
  • laboratories
  • secondary/specialist care
  • primary health care units
  • community organisations providing testing for one or more of these infections
  • National level public health institutions or ministry of health level.
The survey is available in English and Russian and the deadline to complete has been extended to 13 November 2020.
We encourage you to take the survey by clicking here or copy pasting the following link into your browser:
Click to access the survey

Have you been to the #EuroTestWeek website recently?

We have been busy cleaning-up/de-duplicating the sign-up list, adding new translated logos and translating the November 2020 theme statement in Russian!
Don’t forget to check that your organisation is signed-up for ETW and the correct information is being displayed and be sure to download our materials for your activities!

WHO HIV recency assay review

WHO is conducting a review on the use of HIV recency assays in the context of national HTS programmes, with a focus on the individual-level, or clinical, use case. They are keen to collect information on recency assays currently being used by programmes and data (published or unpublished) related to use of these tools.
The review will broadly focus on the following:
  1. Summarize existing evidence on use of recency assays among clients and patients in HTS programmes and/or within HIV case surveillance activities
  2. Review their acceptability, feasibility and effectiveness (including cost-effectiveness)
  3. Identify implementation considerations and evidence on counselling messages and social harm
  4. Define uses of recency assays
If you would like to contribute, please complete their questionnaire and send to Virginia Fonner ( by 30 November 2020.
ETW Twitter page
ETW Facebook page
ETW website
If you no longer want to participate in ETW (both Spring and Autumn), please click the "Opt-out" link below and follow further instructions.

By choosing to "Opt-out" of European Testing Week, your organisation will:
- Be removed from our list of signed-up organisations;
- No longer receive the ETW newsletter, announcements or promotional offers with diagnostic kit companies.

Click here to Opt-Out of European Testing Week
Copyright © 2020 CHIP, EuroTEST, All rights reserved.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.